Page 5 - Thomas Baumert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MIL-OSI: Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis

MIL-OSI: Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.

United statesFrance generalMarion bougeardRoberto iaconeAssia mouhoutJeito capitalleadsaPureos bioventuresJeito capitalamplifiesitsUniversity of strasbourgNovo holdingsFrench national institute of health insermCompany phaseSeries cfinancingAlentis therapeuticsJeito capitalPrivate equity

Novo Holdings invests in US$105 million Series C Funding of Alentis Therapeutics

/PRNewswire/ Novo Holdings A/S, a leading international life sciences investor, today announced it has participated in a new investment in the US$105.

United statesCity ofUnited kingdomSan franciscoRoberto iaconeNaveed siddiqiPureos bioventuresNovo holdingFrench national institute of health insermNovo nordiskSenior partner at novo holdingsInnobio fundNovo holdingsNovo groupNovo nordisk foundationUniversity of strasbourg

Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis

Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1

United statesFrance generalRoberto iaconeAlentis therapeuticstoJeito capitalamplifiesPureos bioventuresAssia mouhoutMarion bougeardFrench national institute of health insermNovo holdingsCompany phaseUniversity of strasbourgJeito capitalAlentis therapeuticsPrivate equityThomas baumert

Alentis Therapeutics Raises US$105M in Series C Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Roberto iaconePureos bioventuresNovo holding naveed siddiqiFrench national institute of health insermUniversity of strasbourgInnobio fundNovo holdingsAlentis therapeuticsJeito capitalAlenti boardThomas baumertFrench national institute

Alentis Therapeutics Lands $105M for Clinical Trials in Fibrosis and Cancer

Three months after Alentis Therapeutics’ lead program posted positive Phase 1 data, the biotech has raised cash to advance that program to mid-stage testing in fibrosis. The Series C financing will also support a cancer drug candidate ready to start human testing.

Thomas baumertPureos bioventuresRoberto iaconeUniversity of strasbourgNovo holdingsFrench national institute of healthSwitzerland based alentisFrench national instituteJeito capitalWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciences